Literature DB >> 31787561

Neuropsychological decline up to 20 years before incident mild cognitive impairment.

Richard J Caselli1, Blake T Langlais2, Amylou C Dueck2, Yinghua Chen3, Yi Su3, Dona E C Locke4, Bryan K Woodruff1, Eric M Reiman3.   

Abstract

INTRODUCTION: Some Alzheimer's disease biomarker studies found amyloid changes 20 years or more in advance of expected symptoms, while cognitive changes lagged for more than a decade, but this apparent lag might reflect the sensitivities of the biomarker and cognitive assays used. How far in advance of incident amnestic mild cognitive impairment (MCI) does cognition begin to decline?
METHODS: Longitudinal neuropsychological study of an apolipoprotein E e4 enriched cohort of cognitively normal individuals at entry. Linear mixed models for MCI converters (n = 65) and nonconverters (n = 719) fitted for each neuropsychological measure; annual changes compared between groups before and after linear model intersections (inflection points).
RESULTS: 34 of 35 cognitive measures and 9 of 18 behavioral measures declined faster post-inflection in the MCI converters; the earliest cognitive inflection point was nearly 20 years in advance of MCI diagnosis. DISCUSSION: The preclinical duration of cognitive and behavioral changes approaches the earliest reported biomarker changes.
© 2019 the Alzheimer's Association.

Entities:  

Keywords:  Age-related cognitive decline; Cognitive aging; Pre-MCI; Preclinical Alzheimer's disease; Preclinical memory decline

Mesh:

Substances:

Year:  2020        PMID: 31787561      PMCID: PMC7067658          DOI: 10.1016/j.jalz.2019.09.085

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  43 in total

1.  The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging.

Authors:  R O Roberts; Y E Geda; D S Knopman; R H Cha; V S Pankratz; B F Boeve; E G Tangalos; R J Ivnik; W A Rocca; R C Petersen
Journal:  Neurology       Date:  2012-01-25       Impact factor: 9.910

2.  Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts.

Authors:  Nienke M E Scheltens; Betty M Tijms; Teddy Koene; Frederik Barkhof; Charlotte E Teunissen; Steffen Wolfsgruber; Michael Wagner; Johannes Kornhuber; Oliver Peters; Brendan I Cohn-Sheehy; Gil D Rabinovici; Bruce L Miller; Joel H Kramer; Philip Scheltens; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2017-04-17       Impact factor: 21.566

3.  Learning and retention in preclinical and early Alzheimer's disease.

Authors:  E Grober; C Kawas
Journal:  Psychol Aging       Date:  1997-03

4.  Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

Authors:  Willemijn J Jansen; Rik Ossenkoppele; Dirk L Knol; Betty M Tijms; Philip Scheltens; Frans R J Verhey; Pieter Jelle Visser; Pauline Aalten; Dag Aarsland; Daniel Alcolea; Myriam Alexander; Ina S Almdahl; Steven E Arnold; Inês Baldeiras; Henryk Barthel; Bart N M van Berckel; Kristen Bibeau; Kaj Blennow; David J Brooks; Mark A van Buchem; Vincent Camus; Enrica Cavedo; Kewei Chen; Gael Chetelat; Ann D Cohen; Alexander Drzezga; Sebastiaan Engelborghs; Anne M Fagan; Tormod Fladby; Adam S Fleisher; Wiesje M van der Flier; Lisa Ford; Stefan Förster; Juan Fortea; Nadia Foskett; Kristian S Frederiksen; Yvonne Freund-Levi; Giovanni B Frisoni; Lutz Froelich; Tomasz Gabryelewicz; Kiran Dip Gill; Olymbia Gkatzima; Estrella Gómez-Tortosa; Mark Forrest Gordon; Timo Grimmer; Harald Hampel; Lucrezia Hausner; Sabine Hellwig; Sanna-Kaisa Herukka; Helmut Hildebrandt; Lianna Ishihara; Adrian Ivanoiu; William J Jagust; Peter Johannsen; Ramesh Kandimalla; Elisabeth Kapaki; Aleksandra Klimkowicz-Mrowiec; William E Klunk; Sebastian Köhler; Norman Koglin; Johannes Kornhuber; Milica G Kramberger; Koen Van Laere; Susan M Landau; Dong Young Lee; Mony de Leon; Viviana Lisetti; Alberto Lleó; Karine Madsen; Wolfgang Maier; Jan Marcusson; Niklas Mattsson; Alexandre de Mendonça; Olga Meulenbroek; Philipp T Meyer; Mark A Mintun; Vincent Mok; José Luis Molinuevo; Hanne M Møllergård; John C Morris; Barbara Mroczko; Stefan Van der Mussele; Duk L Na; Andrew Newberg; Agneta Nordberg; Arto Nordlund; Gerald P Novak; George P Paraskevas; Lucilla Parnetti; Gayan Perera; Oliver Peters; Julius Popp; Sudesh Prabhakar; Gil D Rabinovici; Inez H G B Ramakers; Lorena Rami; Catarina Resende de Oliveira; Juha O Rinne; Karen M Rodrigue; Eloy Rodríguez-Rodríguez; Catherine M Roe; Uros Rot; Christopher C Rowe; Eckart Rüther; Osama Sabri; Páscual Sanchez-Juan; Isabel Santana; Marie Sarazin; Johannes Schröder; Christin Schütte; Sang W Seo; Femke Soetewey; Hilkka Soininen; Luiza Spiru; Hanne Struyfs; Charlotte E Teunissen; Magda Tsolaki; Rik Vandenberghe; Marcel M Verbeek; Victor L Villemagne; Stephanie J B Vos; Linda J C van Waalwijk van Doorn; Gunhild Waldemar; Anders Wallin; Åsa K Wallin; Jens Wiltfang; David A Wolk; Marzena Zboch; Henrik Zetterberg
Journal:  JAMA       Date:  2015-05-19       Impact factor: 56.272

5.  Depressive symptoms in healthy apolipoprotein E ε4 carriers and noncarriers: a longitudinal study.

Authors:  Dona E C Locke; Amylou C Dueck; Cynthia M Stonnington; David S Knopman; Yonas E Geda; Richard J Caselli
Journal:  J Clin Psychiatry       Date:  2013-12       Impact factor: 4.384

6.  Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.

Authors:  Lars Bäckman; Sari Jones; Anna-Karin Berger; Erika Jonsson Laukka; Brent J Small
Journal:  Neuropsychology       Date:  2005-07       Impact factor: 3.295

7.  A computational neurodegenerative disease progression score: method and results with the Alzheimer's disease Neuroimaging Initiative cohort.

Authors:  Bruno M Jedynak; Andrew Lang; Bo Liu; Elyse Katz; Yanwei Zhang; Bradley T Wyman; David Raunig; C Pierre Jedynak; Brian Caffo; Jerry L Prince
Journal:  Neuroimage       Date:  2012-08-03       Impact factor: 6.556

8.  Identification of normal and pathological aging in prospectively studied nondemented elderly humans.

Authors:  D W Dickson; H A Crystal; L A Mattiace; D M Masur; A D Blau; P Davies; S H Yen; M K Aronson
Journal:  Neurobiol Aging       Date:  1992 Jan-Feb       Impact factor: 4.673

9.  Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age.

Authors:  Eloise Kok; Satu Haikonen; Teemu Luoto; Heini Huhtala; Sirkka Goebeler; Hannu Haapasalo; Pekka J Karhunen
Journal:  Ann Neurol       Date:  2009-06       Impact factor: 10.422

10.  Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.

Authors:  Brittany N Dugger; Kathryn Davis; Michael Malek-Ahmadi; Joseph G Hentz; Shawn Sandhu; Thomas G Beach; Charles H Adler; Richard J Caselli; Travis A Johnson; Geidy E Serrano; Holly A Shill; Christine Belden; Erika Driver-Dunckley; John N Caviness; Lucia I Sue; Sandra Jacobson; Jessica Powell; Marwan N Sabbagh
Journal:  BMC Neurol       Date:  2015-08-20       Impact factor: 2.474

View more
  13 in total

1.  Autobiographical Memory Fluency Reductions in Cognitively Unimpaired Middle-Aged and Older Adults at Increased Risk for Alzheimer's Disease Dementia.

Authors:  Matthew D Grilli; Aubrey A Wank; Matthew J Huentelman; Lee Ryan
Journal:  J Int Neuropsychol Soc       Date:  2021-01-29       Impact factor: 2.892

2.  Blood-brain barrier link to human cognitive impairment and Alzheimer's Disease.

Authors:  Giuseppe Barisano; Axel Montagne; Kassandra Kisler; Julie A Schneider; Joanna M Wardlaw; Berislav V Zlokovic
Journal:  Nat Cardiovasc Res       Date:  2022-02-07

3.  APOE genotype, hippocampus, and cognitive markers of Alzheimer's disease in American Indians: Data from the Strong Heart Study.

Authors:  Astrid Suchy-Dicey; Barbara Howard; W T Longstreth; Eric M Reiman; Dedra Buchwald
Journal:  Alzheimers Dement       Date:  2022-02-10       Impact factor: 16.655

4.  Prognostic Value of Learning and Retention Measures from the Free and Cued Selective Reminding Test to Identify Incident Mild Cognitive Impairment.

Authors:  Ellen Grober; Cuiling Wang; Melissa Kitner-Triolo; Richard B Lipton; Claudia Kawas; Susan M Resnick
Journal:  J Int Neuropsychol Soc       Date:  2021-03-22       Impact factor: 3.114

5.  Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.

Authors:  Ellen Grober; Qi Qi; Lynn Kuo; Jason Hassenstab; Richard J Perrin; Richard B Lipton
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  A Comparison of Cross-Sectional and Longitudinal Methods of Defining Objective Subtle Cognitive Decline in Preclinical Alzheimer's Disease Based on Cogstate One Card Learning Accuracy Performance.

Authors:  Shehroo B Pudumjee; Emily S Lundt; Sabrina M Albertson; Mary M Machulda; Walter K Kremers; Clifford R Jack; David S Knopman; Ronald C Petersen; Michelle M Mielke; Nikki H Stricker
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

7.  Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD).

Authors:  Esther S Oh; Paul B Rosenberg; Gail B Rattinger; Elizabeth A Stuart; Constantine G Lyketsos; Jeannie-Marie S Leoutsakos
Journal:  J Am Geriatr Soc       Date:  2020-12-31       Impact factor: 5.562

8.  Association of accelerated long-term forgetting and senescence-related blood-borne factors in asymptomatic individuals from families with autosomal dominant Alzheimer's disease.

Authors:  Jianwei Yang; Chaojun Kong; Longfei Jia; Tingting Li; Meina Quan; Yan Li; Diyang Lyu; Fangyu Li; Hongmei Jin; Ying Li; Qigeng Wang; Jianping Jia
Journal:  Alzheimers Res Ther       Date:  2021-05-27       Impact factor: 6.982

9.  Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers.

Authors:  Anna K Edlund; Kewei Chen; Wendy Lee; Hillary Protas; Yi Su; Eric Reiman; Richard Caselli; Henrietta M Nielsen
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 10.  Preserved Consciousness in Alzheimer's Disease and Other Dementias: Caregiver Awareness and Communication Strategies.

Authors:  Alison Warren
Journal:  Front Psychol       Date:  2021-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.